Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Immune phenotype of peripheral blood mononuclear cells in patients with high-risk non-muscle invasive bladder cancer.

World journal of urology - 1 Nov 2018

Audenet François, Farkas Adam M, Anastos Harry, Galsky Matthew D, Bhardwaj Nina, Sfakianos John P

Abstract excerpt

PURPOSE: To explore the immune phenotype of peripheral blood mononuclear cells (PBMC) in patients with high-risk non-muscle invasive bladder cancer (NMIBC). METHODS: We prospectively collected blood samples from patients with high-risk NMIBC treated at our institution. PBMC were analyzed by flow cytometry to determine the frequency of T cells and NK cells and the expression of immunoregulatory molecules (Tim-3,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to BCG Vaccine
Share to Carcinoma, Transitional Cell

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Disease-Free Survival

Share to Immunotherapy

Share to Leukocytes, Mononuclear

Share to Neoplasm Invasiveness

Share to Statistics, Nonparametric

Share to Urinary Bladder Neoplasms

Source

Open in PubMed Open full text

Identifiers

PMID: 29860605
DOI: 10.1007/s00345-018-2359-7
PMCID: PMC6207464

Genes

TIGIT

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Immune phenotype of peripheral blood mononuclear cells in patients with high-risk non-muscle invasive bladder cancer.PMID 29860605Read ↗

Immune profiles and DNA methylation alterations related with non-muscle-invasive bladder cancer outcomesSemantic proximity Read ↗

Three Conserved Immune Dysfunction and Exclusion Subtypes in Bladder and Pan-cancers: Prognostic and Immunotherapeutic SignificanceSemantic proximity Read ↗

Development of prognostic signature based on immune-related genes in muscle-invasive bladder cancer: bioinformatics analysis of TCGA databaseSemantic proximity Read ↗

HLA class-I genotyping to personalize Bacille Calmette-Guerin immunotherapy in bladder cancer.Semantic proximity Read ↗

The urothelial transcriptomic response to interferon gamma predicts T1 recurrence-free and basal/squamous muscle-invasive bladder cancer survival and better targeted strategies for immune checkpoint blockingSemantic proximity Read ↗

Identification of a Novel Inflamed Tumor Microenvironment Signature as a Predictive Biomarker of Bacillus Calmette-Guérin Immunotherapy in Non-Muscle-Invasive Bladder Cancer.Semantic proximity Read ↗

A TP53-based immune prognostic model for muscle-invasive bladder cancer.Semantic proximity Read ↗

Phenotypic characterization of tumor associated macrophages and circulating monocytes in patients with Urothelial carcinoma of bladder.Semantic proximity Read ↗

A Methylation-Based Reclassification of Bladder Cancer Based on Immune Cell GenesSemantic proximity Read ↗

Comprehensive immune transcriptomic analysis in bladder cancer reveals subtype specific immune gene expression patterns of prognostic relevanceSemantic proximity Read ↗

The Characteristics of Natural Killer Cells and Prediction of Prognosis in Bladder Urothelial CarcinomaSemantic proximity Read ↗

Integrating molecular subtype and CD8+ T cells infiltration to predict treatment response and survival in muscle-invasive bladder cancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.